I have no idea. But the two things that are extremely rare in the OTC are an "Exchange Uplist" (I can only think of three in the last 10 years) and a "Buyback" (I can't think of ANY of substance). When they are talked about buy an OTC CEO it is almost always a red flag because so many do talk about....but it never really happens.
...and I know many think BVTK is "different"...all penny investor's think their stock is "different". At least to this point there is nothing really different. Convertible debt, no significant revenue, history of reverse splits, over use of social media for vague, yet tantalizing "hints", a mailbox for an an office address, one employee, etc etc.
There are SO many things he needs to do before he even considers an uplist or buyback, and without having acccomplished ANY of them...it seems very premature to discuss them. Yet he does.
Just seems a very stinkie pinkie thing to do.
News 
Market Data 
Discover 
